| Inhaled dry powder formulation of tamibarotene, a broad‐spectrum antiviral against respiratory viruses including SARS‐CoV‐2 and influenza virus Q Liao, S Yuan, J Cao, K Tang, Y Qiu, HC Seow, RCH Man, Z Shao, ... Advanced Therapeutics 4 (7), 2100059, 2021 | 20 | 2021 |
| Inhalable neutralizing antibodies–promising approach to combating respiratory viral infections MYT Chow, HW Pan, HC Seow, JKW Lam Trends in pharmacological sciences 44 (2), 85-97, 2023 | 12 | 2023 |
| Spray-dried and spray-freeze-dried powder formulations of an anti-interleukin-4Rα antibody for pulmonary delivery HW Pan, HC Seow, JCK Lo, J Guo, L Zhu, SWS Leung, C Zhang, ... Pharmaceutical Research 39 (9), 2291-2304, 2022 | 12 | 2022 |
| Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration HC Seow, Q Liao, ATY Lau, SWS Leung, S Yuan, JKW Lam International Journal of Pharmaceutics 619, 121704, 2022 | 7 | 2022 |
| Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation HC Seow, JP Cai, HW Pan, C Luo, K Wen, J Situ, K Wang, H Cao, ... Journal of Controlled Release 358, 128-141, 2023 | 5 | 2023 |
| Dual targeting drug delivery strategy for precise medicine: Simultaneous nasal and lung delivery of metallodrug against SARS-CoV 2 S Wang, HC Seow, R Wang, H Li, JKW Lam, H Sun 10th Asian Biological Inorganic Chemistry Conference (28/11/2022-03/12/2022 …, 2022 | | 2022 |
| Development of inhalable powder formulation of broad-spectrum antiviral agent for respiratory viral infections Q Liao, HC Seow, S Yuan, JKW Lam Journal of Aerosol Medicine and Pulmonary Drug Delivery, A4-A5, 2021 | | 2021 |
